Phase I study of sequentially administered recombinant tumor necrosis factor and recombinant interleukin-2.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/925DF6D7.svg?ark=w1%2F20260515%2F925DF6D7)](https://nobleid.org/work/w1/20260515/925DF6D7)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors